Valuation: InterCure Ltd.

Market Cap 168M 0 150M 139M 126M 236M 15.94B 240M 1.67B 658M 8.35B 632M 618M 26.46B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 305M 0 272M 251M 228M 428M 28.86B 434M 3.02B 1.19B 15.12B 1.14B 1.12B 47.9B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
61.79%
Yield 2024 *
-
Yield 2025 -
1 day-0.77%
1 week-6.13%
Current month-15.92%
1 month-16.07%
3 months-4.11%
6 months+3.71%
Current year-12.86%
1 week 1,350
Extreme 1350
1,491
1 month 1,350
Extreme 1350
1,701
Current year 1,126.5
Extreme 1126.5
1,862
1 year 1,126.5
Extreme 1126.5
2,575
3 years 1,126.5
Extreme 1126.5
6,730
5 years 1,126.5
Extreme 1126.5
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 2019-12-23
Director of Finance/CFO 47 2020-02-29
General Counsel - 2022-03-31
Director TitleAgeSince
Director/Board Member 50 2015-09-02
Director/Board Member 67 2014-12-13
Chairman 55 2025-02-12
Date Insider Type Main position Quantity % Market Cap. Importance
3/18/26 Other

Chief Financial Officer

539,947 0.9874%
3/18/26 Other

Director

19,046 0.0348%
3/18/26 Other

Chief Executive Officer

17,285,455 31.6113%
Change 5-day change 1-year change 3-year change Capi.($)
-0.77%-6.13%-43.37%-38.31% 54.13M
-0.64%+1.45%+15.58%+35.82% 121B
+0.74%+2.43%+6.78%+95.06% 101B
+0.61%+2.13%+106.05%+902.51% 59.59B
+1.50%+2.61%-6.79%+78.43% 28.59B
-0.35%+3.37%+32.57%+100.01% 26.85B
-0.13%+3.29%+15.64%+65.93% 26.76B
-0.02%+1.03%+30.49%+393.94% 21.79B
-2.46%-5.71%-23.11%-7.94% 19.57B
-0.70%+2.72%+4.02%+82.89% 19.03B
Average -0.25%-0.18%+13.78%+170.83% 42.42B
Weighted average by Cap. -0.04%+0.61%+24.21%+198.99%

Financials

2024 2025
Net sales 239M 0 213M 197M 179M 335M 22.62B 340M 2.37B 933M 11.85B 897M 877M 37.55B 270M 0 241M 223M 202M 379M 25.59B 385M 2.68B 1.06B 13.41B 1.01B 992M 42.48B
Net income -67.8M -0 -60.51M -55.83M -50.72M -95.15M -6.42B -96.61M -673M -265M -3.36B -254M -249M -10.66B -35.71M -0 -31.87M -29.41M -26.72M -50.12M -3.38B -50.89M -354M -140M -1.77B -134M -131M -5.61B
Net Debt 133M 0 118M 109M 99.32M 186M 12.57B 189M 1.32B 519M 6.59B 498M 488M 20.87B 136M 0 122M 112M 102M 191M 12.91B 194M 1.35B 533M 6.77B 512M 501M 21.43B
Projected Income Statement - Annual - InterCure Ltd.
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
26-10-23 ILA 1,410.00 -0.77% 241
26-10-22 ILA 1,421.00 -1.86% 5,573
26-10-21 ILA 1,448.00 +0.84% 4,068
26-10-20 ILA 1,436.00 +0.56% 10,037
26-10-19 ILA 1,428.00 -4.93% 16,559
  1. Stock Market
  2. Stocks
  3. INCR Stock